Will Beovu Be A Slow-Burning Blockbuster?

DME Data Boosts Novartis Eye Drug

 
• By Kevin Grogan
  
Spy
Novartis spies extra indications for Beovu • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category